Results 171 to 180 of about 30,535,461 (238)

The prevalence of neural tube defects in eastern Ethiopia: A population-based surveillance. [PDF]

PLOS Glob Public Health
Heluf H, Blencowe H, Roba KT, Abebaw S, Dheresa M, Mengesha G, Mohammed MJ, Omere MA, Hassen FA, Tadesse TD, Tilahun Y, Edris Y, Gure T, Assefa N, Madrid L.   +14 more
europepmc   +1 more source

Unraveling the epigenetic code in cancer cell–tumor microenvironment crosstalk

Molecular Oncology, EarlyView.
Epigenetic regulation is a key driver of cancer development and progression. Diverse epigenetic alterations in cancer cells and components of the tumor microenvironment (TME) orchestrate their communication through multiple mechanisms. We discuss how the epigenetic code coordinates bidirectional cancer cell–TME crosstalk to promote cancer progression ...
Ji Hoon Park, Mi‐Young Kim
wiley   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Correction: Cost of illness of scrub typhus in South India - a population-based, mixed-methods study. [PDF]

PLoS Negl Trop Dis
Devamani C, Biran A, Ariyoshi K, John KR, Ross I, Kubo Y, Chandramohan D, Prabhakar Abhilash KP, Schmidt WP.   +8 more
europepmc   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

Hypertension prevalence in the Asia-Pacific region: a systematic analysis of population-based studies. [PDF]

J Pharm Policy Pract
Olson PS, Lee TA, Sarker J, Sawangjit R, Tan BK, Anusornsangiam W, Heru Setiawan C, Ayran CM, Ploylearmsang C, Kifli N, Watcharadamrongkun S, Sookaneknun S, Van HN, Sibounheuang P, Potisarach P, Fern LA, Ngo TL, Chaiyakunapruk N, Thundee C, Leelathanalerk A.   +19 more
europepmc   +1 more source

On “Weak” and “Strong” Population Momentum

, 2009
Levin, Simon A., Espenshade, Thomas J., Olgiati, Analia S.   +2 more
core  

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study. [PDF]

JACC Adv
Chauhan A, Giannakeas V, Thiruchelvam D, Thavendiranathan P, Amir E, Nadler MB, Savard MF, Abdel-Qadir H.   +7 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source